Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02978 |
| Species: | Mus musculus |
| Position : | chr2:91067374-91069374 |
| Year: | 2014 |
| Title: | The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | Leukemia |
| PMID: | 25185713 |
| Tissue: | blood / hematopoietic system |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Bone Marrow Cell,Leukemic Stem Cell,Hematopoietic Stem Cell,416B |
| Experiment Type: | TF-binding/chromatin assay; Chromatin interaction assay; In vivo functional validation; Disease-associated enhancer analysis |
| Low Throughput Method: | ChIP-qPCR/ChIP; 3C; Transgenic/LacZ assay |
| Target gene : | Spi1 |
| TF name : | Runx1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Runx1 | AndrogenReceptor | netpath | 167 |
| Runx1 | Organic cation transport | reactome | 9 |
| Runx1 | RANKL | netpath | 84 |
| Runx1 | Regulation of nuclear SMAD2/3 signaling | pid | 82 |
| Runx1 | TGF_beta_Receptor | netpath | 220 |
| Runx1 | Validated transcriptional targets of deltaNp63 isoforms | pid | 47 |
| Runx1 | Pathways in cancer | kegg | 321 |
| Runx1 | Chronic myeloid leukemia | kegg | 69 |
| Runx1 | Acute myeloid leukemia | kegg | 53 |